The European Medicines Agency (EMA) has recently revised the Question and Answer (Q&A) document that provides practical considerations concerning the implementation of the medical devices (MDR) and the in vitro diagnostic medical devices (IVDR) regulations.
The Q&A document has been developed to provide guidance to applicants on aspects within the scope of the Agency’s activities and should always be read in conjunction with the new MDR and IVDR.
The recent update of this document focuses on aspects relating to the implementation and applicability of the requirements of Regulation (EU) 2017/745 to medicinal products with an integral or co-packaged medical device.
Asphalion is supporting a large number of companies during development, manufacturing, validation, certification and commercialization of Medical Devices in Europe and United States, according to the applicable legislations.
If you are interested to obtain specialized advisory about how to accomplish European Commission requirements about fair market access for Medical Devices, please contact us at: info@asphalion.com
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Proceeds to support clinical development of lead first-in-class progra...
